+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Mental Disorders Drugs Market Research Reports

South Korea Dysthymia Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

South Korea Dysthymia Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • April 2022
  • 40 Pages
  • South Korea
From
United States Dysthymia Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

United States Dysthymia Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • April 2022
  • 40 Pages
  • United States
From
Vietnam Dysthymia Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027 - Product Thumbnail Image

Vietnam Dysthymia Drugs Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2027

  • Report
  • April 2022
  • 40 Pages
  • Vietnam
From
Dysthymia Drugs Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027 - Product Thumbnail Image

Dysthymia Drugs Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2027

  • Report
  • March 2022
  • 100 Pages
  • Global
From
Depression Treatment Drugs Industry Forecasts - China Focus - Product Thumbnail Image

Depression Treatment Drugs Industry Forecasts - China Focus

  • Report
  • March 2025
  • 100 Pages
  • China
From
Depression Treatment Drugs Companies in China - Product Thumbnail Image

Depression Treatment Drugs Companies in China

  • Report
  • March 2025
  • 55 Pages
  • China
From
Schizophrenia Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Thumbnail Image

Schizophrenia Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • January 2024
  • 185 Pages
  • Global
Attention Deficit Hyperactivity Disorder Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Thumbnail Image

Attention Deficit Hyperactivity Disorder Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • December 2023
  • 250 Pages
  • Global
Fibromyalgia Antidepressants Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) - Product Thumbnail Image

Fibromyalgia Antidepressants Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

  • Report
  • November 2023
  • 231 Pages
  • Global
Global Psychedelic Drugs Market 2030 by Source, Drug Type, Distribution Channel and Region - Partner & Customer Ecosystem Competitive Index & Regional Footprints - Product Thumbnail Image

Global Psychedelic Drugs Market 2030 by Source, Drug Type, Distribution Channel and Region - Partner & Customer Ecosystem Competitive Index & Regional Footprints

  • Report
  • August 2023
  • 180 Pages
  • Global
From
Olanzapine Market by Application, Route of Administration, Distribution Channel, and Geography: Forecast to 2027 - Product Thumbnail Image

Olanzapine Market by Application, Route of Administration, Distribution Channel, and Geography: Forecast to 2027

  • Report
  • July 2023
  • 214 Pages
  • Global
From
Global Digital Therapeutics for Behavioral Health Market - 2022 Report - Product Thumbnail Image

Global Digital Therapeutics for Behavioral Health Market - 2022 Report

  • Report
  • December 2022
  • Global
Market Spotlight: Attention Deficit Hyperactivity Disorder (ADHD)? - Product Thumbnail Image

Market Spotlight: Attention Deficit Hyperactivity Disorder (ADHD)?

  • Report
  • February 2021
  • 56 Pages
  • Global
Psychedelic Drugs Market, By Drugs (LSD, Ecstasy, Phencyclidine, GHB, Ketamine, Ayahuasca, Psilocybin), Route of Administration (Oral, Injectable, Inhalation), Distribution Channel, End-Users, Application and Geography - Global Forecast to 2026 - Product Thumbnail Image

Psychedelic Drugs Market, By Drugs (LSD, Ecstasy, Phencyclidine, GHB, Ketamine, Ayahuasca, Psilocybin), Route of Administration (Oral, Injectable, Inhalation), Distribution Channel, End-Users, Application and Geography - Global Forecast to 2026

  • Report
  • December 2020
  • 200 Pages
  • Global
Latuda (lurasidone; Sumitomo Dainippon/Angelini) Drug Overview 2019 - Product Thumbnail Image

Latuda (lurasidone; Sumitomo Dainippon/Angelini) Drug Overview 2019

  • Report
  • March 2019
  • 39 Pages
  • Global
Abilify/Abilify Maintena Drug Overview 2019 - Product Thumbnail Image

Abilify/Abilify Maintena Drug Overview 2019

  • Report
  • March 2019
  • 62 Pages
  • Global
Rexulti (brexpiprazole) Drug Overview 2019 - Product Thumbnail Image

Rexulti (brexpiprazole) Drug Overview 2019

  • Report
  • March 2019
  • 33 Pages
  • Global
Lexapro (escitalopram; Allergan/Lundbeck/Mitsubishi Tanabe/Mochida) Drug Overview 2019 - Product Thumbnail Image

Lexapro (escitalopram; Allergan/Lundbeck/Mitsubishi Tanabe/Mochida) Drug Overview 2019

  • Report
  • March 2019
  • 16 Pages
  • Global
Pristiq (desvenlafaxine; Pfizer) Drug Overview 2019 - Product Thumbnail Image

Pristiq (desvenlafaxine; Pfizer) Drug Overview 2019

  • Report
  • March 2019
  • 17 Pages
  • Global
Fetzima (levomilnacipran; Allergan) Drug Overview 2019 - Product Thumbnail Image

Fetzima (levomilnacipran; Allergan) Drug Overview 2019

  • Report
  • March 2019
  • 17 Pages
  • Global
Loading Indicator

The Mental Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat mental health conditions. These drugs are used to treat a wide range of mental health issues, including depression, anxiety, bipolar disorder, schizophrenia, and attention deficit hyperactivity disorder (ADHD). The market is highly competitive, with many companies vying for market share. The Mental Disorders Drugs market is driven by the increasing prevalence of mental health issues, as well as the growing demand for effective treatments. Additionally, advances in technology and research have enabled the development of more effective drugs. Some of the major players in the Mental Disorders Drugs market include Pfizer, GlaxoSmithKline, Eli Lilly, Johnson & Johnson, and AstraZeneca. These companies are engaged in the development and production of drugs used to treat mental health conditions. Additionally, they are involved in research and development activities to develop new drugs and treatments. Show Less Read more